USFDA gives final nod to Zydus Lifesciences’ generic version of insomnia drug

The drug, triazolam, is used on a short-term basis to treat insomnia

Zydus Lifesciences last week said it has received final approval from the United States Food and Drug Administration (USFDA) to market its generic version of triazolam tablets used on a short-term basis to treat insomnia.

Edits by EP News Bureau


insomnia drugtriazolam tabletsUSFDA approvalZydus Lifesciences
Comments (2)
Add Comment
  • djamila_st

    Good post but I was wondering if you could write a litte more on this subject? I’d be very thankful if you could elaborate a little bit further. Appreciate it!

  • soundos

    thanks for sharing all info!